Charles H Mitch - Lilly Research Laboratories, Eli Lilly and Company

基本信息

浏览量：28

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 73 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Preclinical Predictors That the Orthosteric Mglu2/3 Receptor Antagonist LY3020371 Will Not Engender Ketamine-Associated Neurotoxic, Motor, Cognitive, Subjective, or Abuse-Liability-related Effects

J. M. Witkin,J. A. Monn,J. Li,B. Johnson,D. L. Mckinzie,X-S Wang,B. A. Heinz, R. Li,P. L. Ornstein,S. C. Smith,C. H. Mitch,D. O. Calligaro,S. Swanson, D. Allen,K. Phillips,G. Gilmour

Pharmacology, biochemistry, and behavior（2017）

引用23浏览0WOS引用

Metabotropic Glutamate Receptor

M.D. Chappell, R. Li,S.C. Smith,B.A. Dressman, E.G. Tromiczak, A.E. Tripp, M.-J. Blanco, T. Vetman,S.J. Quimby, J. Matt, T. Britton,A.M. Fivush,J.M. Schkeryantz,D. Mayhugh, J.A. Erickson,M. Bures, C. Jaramillo,M. Carpintero, J.E. de Diego, M. Barberis, S. Garcia-Cerrada, J.F. Soriano,S. Antonysamy,S. Atwell,I. MacEwan,B. Condon, C. Bradley, J. Wang, A. Zhang,K. Conners,C. Groshong,S.R. Wasserman,J.W. Koss,J.M. Witkin, X. Li,C. Overshiner,K.A. Wafford, W. Seidel,X.-S. Wang,B.A. Heinz,S. Swanson,J. Catlow,D. Bedwell,J.A. Monn,C.H. Mitch,P. Ornstein

crossref（2016）

引用7浏览0引用

Metabotropic Glutamate Receptor in complex with antagonist (1~{S},2~{R},3~{S},4~{S},5~{R},6~{R})-2-azanyl-3-[[3,4-bis(fluoranyl)phenyl]sulfanylmethyl]-4-oxidanyl-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid

M.D. Chappell, R. Li,S.C. Smith,B.A. Dressman, E.G. Tromiczak, A.E. Tripp, M.-J. Blanco, T. Vetman,S.J. Quimby, J. Matt, T. Britton,A.M. Fivush,J.M. Schkeryantz,D. Mayhugh, J.A. Erickson,M. Bures, C. Jaramillo,M. Carpintero,J.E. de Diego, M. Barberis, S. Garcia-Cerrada, J.F. Soriano,S. Antonysamy,S. Atwell,I. MacEwan,B. Condon, C. Bradley, J. Wang, A. Zhang,K. Conners,C. Groshong,S.R. Wasserman,J.W. Koss,J.M. Witkin, X. Li,C. Overshiner,K.A. Wafford, W. Seidel, X.-S. Wang,B.A. Heinz,S. Swanson,J. Catlow,D. Bedwell,J.A. Monn,C.H. Mitch,P. Ornstein

crossref（2016）

引用0浏览0引用

In vitro Attributes of LY3020371, a Potent and Selective mGlu2/3 Receptor Antagonist

J. A. Monn,J. M. Witkin,P. L. Ornstein,C. H. Mitch, R. Li,S. C. Smith,X. Wang,C. Xiang,J. H. Carter, J. Wang,S. Atwell, F. Pasqui, S. Fitzjohn,B. A. Heinz

CURRENT NEUROPHARMACOLOGY（2014）

引用0浏览0引用

Divergent effects of mu-opioid antagonism on insulin secretion from human islets and efficacy in type 2 diabetic patients

K. Bokvist, F. Zhang,M. A. Statnick, M. E. Christe,C. H. Mitch, W. Shen, X. Peng, H. -R. Qian,J. K. Leohr,J. W. Miller

DIABETOLOGIA（2011）

引用0浏览0引用

Short-Term Safety And Pharmacodynamic Effects Of Ly2076962, An Opioid Receptor Inverse Agonist

J. W. Miller,J. W. Witcher, E. Lobo,M. A. Statnick,C. H. Mitch, A. J. Long, L. S. Fogle,J. G. Suico,D. Renard

CLINICAL PHARMACOLOGY & THERAPEUTICS (2007): S63-S64

引用0浏览0引用

Central Opioid and Mesolimbic Dopamine Neurotransmission Forms a Nexus of Neural Pathways Supporting Motivation, Palatability, Drug Addiction and Obesity

M.A. Statnick,C.H. Mitch,D.K. Sindelar,T. Coskun,J.E. Pintar,D.R. Gehlert,L.A. Phebus, K.A. Svensson,H.E. Shannon,D.L. McKinzie,J. Eastwood,J. Emmerson,M.L. Heiman

Neuropeptides（2006）

引用0浏览0引用

Localization of Opioid Receptor Antagonist [3H]-LY255582 Binding Sites in Mouse Brain: Comparison with the Distribution of Mu, Delta and Kappa Binding Sites

SL Gackenheimer,TM Suter,JE Pintar,SJ Quimby,WJ Wheeler,CH Mitch,DR Gehlert,MA Statnick

Neuropeptides（2005）

引用26浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn